NCT06608043

Brief Summary

The aim of this study is to investigate the effects of the reborn lifestyle regulation program on physical activity, fatigue level, pain, mental health burden and quality of life in breast cancer patients.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Aug 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2024

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

September 19, 2024

Completed
4 days until next milestone

First Posted

Study publicly available on registry

September 23, 2024

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2025

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2025

Completed
Last Updated

September 23, 2024

Status Verified

August 1, 2024

Enrollment Period

6 months

First QC Date

September 19, 2024

Last Update Submit

September 19, 2024

Conditions

Outcome Measures

Primary Outcomes (7)

  • Breast Cancer Specific Quality of Life Scale

    An adjunct to the EORTC QLQ-C30, this scale assesses breast cancer-specific symptoms and treatment-related side effects. It includes subscales for body image, sexual function, and treatment side effects, rated on a 4-point Likert scale. The Turkish version was adapted by Demirci et al. in 2011.

    12 weeks

  • Modified Borg Scale

    Developed by Borg in 1970, this unidirectional scale (0-10) measures the effort exerted during physical exercise, particularly in assessing dyspnea severity. Participants rate their dyspnea over the past week, with "0" indicating no shortness of breath and "10" indicating severe shortness of breath.

    12 weeks

  • Sit up Test

    This test measures leg strength and endurance by counting how many times a participant can sit and stand from a chair within 30 seconds. A score of fewer than 10 sit-ups indicates lower extremity weakness. The Turkish validity and reliability were established by Demir and Öztürk in 2020.

    12 weeks

  • Cancer Fatigue Scale

    The CFS, developed by Okuyama et al. (2000) and validated in Turkish by Şahin et al. (2018), evaluates fatigue in individuals with cancer across three domains: physical, emotional, and cognitive. The scale consists of 15 items, rated on a Likert scale from 1 (not at all) to 5 (very much).

    12 weeks

  • McGill-Melzack Pain Questionnaire

    Developed by Melzack in the 1970s and validated in Turkish by Kuguoglu et al. (2003), the MPQ assesses the quality and intensity of pain through four sections, including sensory and perceptual dimensions. Scores range from 0 to 112, with higher scores indicating more severe pain.

    12 weeks

  • Depression Anxiety Stress Scale (DASS-21)

    The DASS-21, developed by Lovibond \& Lovibond (1995) and validated in Turkish by Sarıçam (2018), assesses mental health across three dimensions: depression, anxiety, and stress. Each dimension consists of 7 items rated on a 4-point Likert scale. Higher scores indicate more severe symptoms.

    12 weeks

  • Pittsburgh Sleep Quality Index (PSQI)

    Developed by Buyyse et al. (1989) and validated in Turkish by Agargun et al., the PSQI assesses sleep quality over the past month across seven components. Scores range from 0 to 21, with higher scores indicating poorer sleep quality.

    12 weeks

Secondary Outcomes (4)

  • European Organization for Research and Treatment of Cancer Quality of Life Scale

    12 weeks

  • University of Rhode Island Scale for Assessing Change

    Baseline

  • Mini Mental Status Examination Test

    Baseline

  • Visual Analog Scale

    12 weeks

Study Arms (2)

Intervention Group

This intervention group consists of multi-component modules developed to help individuals with breast cancer adopt a healthy lifestyle and improve their quality of life. The sessions are based on the 'Do Live Well' model, Kolb's Experiential Learning Theory, and CBT-based problem-solving skills.

Behavioral: Reborn lifestyle adjustment program

Control Group

Patients in the control group will continue conventional medical treatments, occupational therapy and physiotherapy sessions.

Procedure: Conventional Physiotherapy and Occupational Therapy

Interventions

The sessions are based on the 'Do Live Well' model, Kolb's Experiential Learning Theory, and CBT-based problem-solving skills. Introduction to the Reborn Lifestyle: Core principles of the Reborn Program for building a healthy lifestyle during and after breast cancer. Physical Activity: The role of physical activity during treatment and exercises to boost energy levels. Fatigue Management: Scientific methods for managing fatigue during and after treatment. Pain Management: Effective techniques to reduce pain and improve quality of life. Mental Health Burden: Strategies to alleviate mental health burdens and cope with stress. Quality Sleep: Practical methods to improve sleep patterns and achieve quality rest. Preventive Rehabilitation Approaches: Essential rehabilitation strategies to protect health and reduce recurrence risk. The study will be conducted online, with evaluations and sessions via Zoom before and after the 12-week modules.

Intervention Group

Patients in the control group will continue conventional medical treatments, occupational therapy and physiotherapy sessions.

Control Group

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Female patients with breast cancer

You may qualify if:

  • Being a female individual aged 18 or older
  • Have been diagnosed with Stage I, II, or III breast cancer
  • At least 6 months have passed since the completion of chemotherapy
  • Approval by an oncologist to participate in the study
  • Having internet access and the ability to connect online
  • Scoring above 23 on a standardized Mini Mental Status Examination Test
  • Being in the contemplation stage according to the Transtheoretical Model

You may not qualify if:

  • Having a neurological or systemic disease that could significantly affect the course of the intervention
  • Having metastasis that could impact the sustainability of the study
  • Suffering from neuropathic pain
  • Having participated in a healthy lifestyle program within the last 3 months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Istanbul Atlas University

Istanbul, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

Breast Neoplasms

Interventions

Occupational Therapy

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Intervention Hierarchy (Ancestors)

RehabilitationAftercareContinuity of Patient CarePatient CareTherapeutics

Study Officials

  • Sena Ondes, MSc

    Atlas University

    STUDY CHAIR

Central Study Contacts

Sena Ondes, MSc

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 19, 2024

First Posted

September 23, 2024

Study Start

August 1, 2024

Primary Completion

February 1, 2025

Study Completion

August 1, 2025

Last Updated

September 23, 2024

Record last verified: 2024-08

Data Sharing

IPD Sharing
Will not share

Locations